==== Front
Cureus
Cureus
2168-8184
Cureus
2168-8184
Cureus Palo Alto (CA)

10.7759/cureus.39763
Medical Education
Neurology
Epidemiology/Public Health
The Association of Sociodemographic Factors, Postictal Symptoms, and Medical History With Seizure Type in Patients With Epilepsy: A Cross-Sectional Study
Muacevic Alexander
Adler John R
Alyoubi Reem 1
Kobeisy Summayah A 2
Basheikh Mazen 3
Al-Sharief Rayan A 4
Al-Hayani Majed M 4
Rayes Yousof O 4
Alharthi Atheer 5
Alyazidi Anas S 67
Alrayes Nuha 8
Tayeb Haythum O 910
1 Department of Pediatrics, King Abdulaziz University Hospital, Jeddah, SAU
2 Department of Pediatrics, Dr. Soliman Fakeeh Hospital, Jeddah, SAU
3 Department of Internal Medicine, University of Jeddah, Jeddah, SAU
4 Department of Medicine, King Abdulaziz University, Rabigh, SAU
5 Department of Medicine and Surgery, Umm Al-Qura University, Makkah, SAU
6 Department of Medicine, King Abdulaziz University Hospital, Jeddah, SAU
7 Department of Medicine, King Abdulaziz University, Jeddah, SAU
8 Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, SAU
9 Department of Medicine, Neuroscience Research Unit, Faculty of Medicine, King Abdulaziz University, Jeddah, SAU
10 Department of Neurology, Faculty of Medicine, King Abdulaziz University, Jeddah, SAU
Reem Alyoubi reem.alyoubi@hotmail.com
31 5 2023
5 2023
15 5 e3976329 5 2023
Copyright © 2023, Alyoubi et al.
2023
Alyoubi et al.
https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article is available from https://www.cureus.com/articles/127895-the-association-of-sociodemographic-factors-postictal-symptoms-and-medical-history-with-seizure-type-in-patients-with-epilepsy-a-cross-sectional-study
Background

Approximately 50 million people globally suffer from epilepsy. The prevalence of epilepsy in Saudi Arabia has been reported at 6.5 per 1,000 persons, affecting nearly 1% of the entire population. However, limited data is available in the country regarding the sociodemographic factors affecting epilepsy and its associated postictal symptoms, which may lead to stigmatization and negatively impact patients.

Methods

A cross-sectional study was conducted at King Abdulaziz University Hospital (KAUH) in a survey format. Ethical approval was obtained from the Research Ethics Committee of the Faculty of Medicine at King Abdulaziz University. The study population included patients with epilepsy who visited King Abdulaziz University Hospital’s outpatient neurology clinics from October 2021 to March 2022.

Results

The study participants’ average age at the time of the first seizure was 16.5 years, with patients experiencing seizures as early as within the first year of life and as late as 70 years of age. Patients who had had their first seizure during the first year of life did not have any schooling (p<0.0001) and had learning difficulties (p<0.00001). Focal onset impaired awareness seizures were significantly associated with motor weakness (p=0.023) and mood alterations (p=0.014), while postictal fear, anxiety or panic, and sleep disruption were statistically significant for focal onset aware seizures (p=0.015 and p=0.050).

Conclusion

This study highlights the sociodemographic differences between patients in Saudi Arabia and in other areas. It may also point to novel findings regarding the postictal symptoms associated with the various seizure types.

sociodemographic
epidemiology
seizure
saudi arabia
epilepsy
==== Body
pmcIntroduction

Epilepsy is a chronic brain disease causing transient abnormal cerebral activity that may lead to seizures, unusual behavior, sensations, or loss of consciousness. It is estimated that epilepsy affects 50 million people worldwide with an annual cumulative incidence of 67.77 per 100,000 persons [1-3]. Its prevalence is expected to increase due to increased life expectancy and advancements in the medical field that lead to improved survival rates of those with traumatic brain injuries, perinatal injury, central nervous system infections, and stroke, which are all causes of epilepsy [1]. The disease burden of epilepsy differs across countries and accounts for roughly 1% of the disease burden worldwide [2]. Almost 80% of people with epilepsy come from low- to middle-income countries; mortality rates due to the disease in these countries are also higher [2,4]. In 2017, the International League Against Epilepsy (ILAE) reclassified seizure nomenclature to better aid the clinician in describing the disorder and help patients in understanding their condition [3]. Seizures previously referred to as simple partial and complex partial are now known as focal onset aware and focal onset impaired awareness seizures [4]. Epilepsy is prevalent in Saudi Arabia, with an incidence rate of 6.5 per 1,000 people [5]. Generally in the Middle East and specifically in Saudi Arabia, limited data is available regarding sociodemographic factors affecting epilepsy and public awareness levels regarding the disease, which may lead to stigmatization and negatively impact those affected [6-9]. The aim of this study is to explore sociodemographic characterizations of epilepsy patients in Saudi Arabia and report their postictal symptoms and past medical history.

Materials and methods

Study design and ethical considerations

A cross-sectional study was conducted at King Abdulaziz University Hospital (KAUH) in a survey format distributed in the clinic and online using patients’ phone numbers in the hospital record. Ethical approval was obtained from the Research Ethics Committee of the Faculty of Medicine at King Abdulaziz University in Jeddah, Saudi Arabia (reference number: 199-22), and the guidelines outlined in the Declaration of Helsinki were followed. Furthermore, the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist [10] was adopted for the present study.

Study population

The study population included patients who visited the KAUH outpatient neurology clinics from October 2021 to March 2022. Criteria for inclusion were patients previously diagnosed with epilepsy and following up in the KAUH outpatient neurology clinics during the study period. Written informed consent was required as well as parental consent for those less than 18 years old.

Sampling methodology

The survey comprised three sections. The first included a consent question, in which participants gave consent to proceed to the following section. The second included demographic data such as age, gender, and marital status. The third solicited information on seizure type, age at the time of first seizure, seizure frequency, and presence of convulsions. The occurrence of status epilepticus was also included. The survey encompassed postictal symptoms and past medical history as well as family history. Data were collected and entered into a database.

Data analysis

The data used to conduct this survey and support the findings are available upon request from the corresponding author. Statistical analysis was carried out using Statistical Package for the Social Sciences (SPSS) version 20 (IBM SPSS Statistics, Armonk, NY, USA). The level of significance (p-value) was taken at <0.05. The Bonferroni correction was used in post hoc testing of the data.

Results

There were a total of 121 study participants. Their average age was 30.5 years, with the youngest being 12 and the oldest being 76. Most patients were between the ages of 18 and 29 years (50.4%), and only two patients were in the senior citizen age group (Figure 1). The patients’ average age at the time of the first seizure was 16.5 years, with patients experiencing seizures as early as within the first year of life and as late as 70 years of age. The majority of patients had experienced their first seizure between the ages of three and 17 years (39.7%), followed by those between the ages of 18 and 29 years (24.8%). The majority of the cohort (60.4%) had experienced their first seizure below 18 years of age (Figure 2). Females constituted the majority of the sample (52.9%), and the majority were nonsmokers (81.8%). Only 34.8% had received higher education, and 62% were single. Regarding seizure type, the most common was generalized onset (73.6%), followed by focal onset impaired awareness (52.9%) and focal onset awareness (34.7%). The incidence of generalized onset seizures among those with focal onset impaired awareness was higher than those with focal onset awareness seizures (79.7% and 69%, respectively). Of the group, 29.8% reported having experienced status epilepticus, and 19% experienced daily seizures (Table 1).

Figure 1 Age Group Distribution of the Study Participants Displaying a Majority of Participation by Young Adults

Figure 2 Different Age Groups According to the Reporting Age of First Seizures

Table 1 Demographic Characteristics of Patients

SD: standard deviation

Demographic characteristics	
Age group	Number (%)	
Pediatric (0-17)	9 (7.4)	
Young adult (18-29)	61 (50.4)	
Middle age (30-49)	39 (32.2)	
Older adult (50-64)	10 (8.3)	
Senior citizen (>65)	2 (1.7)	
Age	 	
Mean±SD	30.5±12.6	
Minimum-maximum	12-76	
Age at first seizure	 	
Mean±SD	16.5±14.5	
Minimum-maximum	0-70	
Age at first seizure	Number (%)	
Infant (<1)	6 (5)	
Toddler (1-3)	19 (15.7)	
Pediatric (>3-17)	48 (39.7)	
Young adult (18-29)	30 (24.8)	
Middle age (30-49)	12 (9.9)	
Older adult (50-64)	5 (4.1)	
Senior citizen (>65)	1 (0.8)	
Gender	Number (%)	
Male	57 (47.1)	
Female	64 (52.9)	
Smoking status	Number (%)	
Smoker	22 (18.2)	
Nonsmoker	99 (81.8)	
Educational status	Number (%)	
No education	18 (14.9)	
Less than high school diploma	18 (14.9)	
High school diploma	43 (35.5)	
Bachelor’s degree	36 (29.8)	
Postgraduate degree	6 (5)	
Marital status	Number (%)	
Single	75 (62)	
Married	45 (37.2)	
Divorced	1 (0.8)	
Focal onset aware seizure	Number (%)	
Yes	42 (34.7)	
No	79 (65.3)	
Focal onset impaired awareness seizure	Number (%)	
Yes	64 (52.9)	
No	57 (47.1)	
Generalized seizure	Number (%)	
Yes	89 (73.6)	
No	32 (26.4)	
Status epilepticus	Number (%)	
Yes	36 (29.8)	
No	85 (70.2)	
Seizure frequency	Number (%)	
Never	7 (5.8)	
Daily	23 (19)	
Weekly	14 (11.6)	
Monthly	39 (28.9)	
Annually	38 (31.4)	

Of the postictal symptoms, motor weakness was the most common (66.1%), followed by confusion (62.8%) and sleep disruption (52.9%). Only 9% of the patients experienced postictal hallucinations (Table 2).

Table 2 Detailed Postictal Symptom Data

Postictal symptoms	
Confusion	Number (%)	
Yes	76 (62.8)	
No	45 (37.2)	
Motor weakness	Number (%)	
Yes	80 (66.1)	
No	41 (33.9)	
Sensory loss	Number (%)	
Yes	35 (28.9)	
No	86 (71.1)	
Disruptive behavior	Number (%)	
Yes	27 (22.3)	
No	94 (77.7)	
Hallucination	Number (%)	
Yes	11 (9.1)	
No	110 (90.9)	
Fear, anxiety, or panic	Number (%)	
Yes	23 (19)	
No	98 (81)	
Mood alterations	Number (%)	
Yes	36 (29.8)	
No	85 (70.2)	
Sleep disruption	Number (%)	
Yes	64 (52.9)	
No	57 (47.1)	

Nearly one-fourth of patients reported a family history of epilepsy (24.8%), and 36.4% had a family history of consanguinity. However, learning difficulties and developmental delay were reported at 13.2% and 11.6%, respectively, in each of the above groups. A little more than a third of patients were documented to have previous head trauma (33.9%), while only 5.8% had had a central nervous system infection, and 12.4% had experienced a febrile convulsion (Table 3).

Table 3 Detailed Medical History of Patients

Past medical history	
Neurological disorder	Number (%)	
Yes	30 (24.8)	
No	91 (75.2)	
Birth difficulty	Number (%)	
Yes	12 (9.9)	
No	109 (90.1)	
Developmental delay	Number (%)	
Yes	14 (11.6)	
No	107 (88.4)	
Learning difficulties	Number (%)	
Yes	16 (13.2)	
No	105 (86.8)	
Head trauma	Number (%)	
Yes	41 (33.9)	
No	80 (66.1)	
Febrile convulsion	Number (%)	
Yes	15 (12.4)	
No	106 (87.6)	
Meningitis/encephalitis	Number (%)	
Yes	7 (5.8)	
No	114 (94.2)	
Family history of epilepsy	Number (%)	
Yes	30 (24.8)	
No	91 (75.2)	
Family history of consanguinity	Number (%)	
Yes	44 (36.4)	
No	77 (63.6)	
Psychiatric comorbidity	Number (%)	
Yes	9 (7.4)	
No	112 (92.6)	
Psychiatric follow-up	Number (%)	
Yes	13 (10.7)	
No	108 (89.3)	
Psychiatric treatment	Number (%)	
Yes	5 (4.1)	
No	116 (95.9)	

Age of first seizure was statistically significant for marital status, patient’s educational status, history of neurological disorder, history of learning difficulties, history of head trauma, history of febrile convulsion, and patient’s smoking status. Using the Bonferroni adjusted significance value, only those who had had their first seizure during the first year of life were statistically found to have no educational background (p<0.0001) and learning difficulties (p<0.00001).

Discussion

Worldwide, epilepsy is known to have a bimodal age distribution, peaking in infancy and adults above the age of 50 [11]. However, 39.7% of patients in this study experienced their first seizure between the ages of >3 and 17 years. Only 5% were less than one year of age, and 4.9% were 50 years and above at the time of their first seizure. Unexpectedly, 60.4% of the participants had experienced their first seizure before the age of 18. A little more than half of those studied were female (52.9%). This is contrary to results reported in the literature where the incidence of epilepsy is higher in males than in females [12]. The great majority (62.8%) of this study’s cohort were either single or divorced. Divorce rates in women with epilepsy are higher than those of men, and people with epilepsy are more likely to face marital stigma and divorce [13]. Only 18.2% of those studied were found to be smokers, compared to a study in the United States that demonstrated that 24% of epilepsy patients were smokers [14]. These differences may highlight regional distinctions in the sociodemographic backgrounds of those affected with epilepsy. Focal onset impaired awareness seizures were more common among study participants than focal onset aware seizures (52.9% and 34.7%, respectively). However, the majority reported generalized onset seizures (73.6%). Among epilepsy patients, focal seizures are the most common, with focal onset impaired awareness seizures being the most common subtype [15]. Of those surveyed, 29.8% reported having status epilepticus. A systematic review found that 30%-44% of those with status epilepticus have a history of epilepsy, thus denoting a strong relationship between those with epilepsy and status epilepticus [16]. Regarding seizure frequency, almost one-fifth reported daily seizures. This may indicate poor compliance with medication, treatment-refractory seizure, or inadequate medical management.

The ill-defined period after a seizure, otherwise known as the postictal state, is not well understood; there is limited research regarding this topic [17,18]. Motor weakness (66.1%), confusion (62.8%), and sleep disruption (52.9%) were the most common postictal symptoms found. Among those studied, there were significant statistical differences between types of seizure and the associated postictal symptoms. Altered consciousness, headache, paresis, and psychiatric symptoms are common postictal symptoms associated with generalized onset seizures [18]. Headaches and migraines after seizures are common in both adults and pediatrics but more so among the latter [16]. Participants with generalized onset seizures in this study were found to have statistically significant postictal confusion (p=0.001), motor weakness (p≤0.0001), and sensory loss (p=0.017). Focal onset impaired awareness seizures were associated with motor weakness (p=0.023) and mood alterations (p=0.014), while postictal fear, anxiety, or panic, and sleep disruption were statistically significant for focal onset aware seizures (p=0.015 and p=0.050, respectively). Studies have reported postictal unresponsiveness as the most common symptom with an occurrence of 96%. Those with refractory focal epilepsy are most likely to have postictal memory impairment (66%) [18]. Interestingly, the literature contains sparse data comparing postictal symptoms of focal awareness and focal impaired awareness seizures. To the best of the author’s knowledge, this may be a groundbreaking finding regarding the differences between these two seizure types.

Literature has shown that patients with epilepsy are more likely to have developmental delays and learning setbacks, especially in school, than those without the disease [19-22]. Those studied and reported to have generalized onset seizures were found to have a statistically significant history of developmental delay and learning difficulties (p=0.017 and p=0.010, respectively). Patients with focal onset aware seizures were also found to have a statistically important history of learning difficulties (p=0.045), while those with focal onset impaired awareness seizures had a history of febrile convulsions and head trauma (p=0.025 and p=0.010, respectively). Other studies have also shown a correlation between febrile seizures and epilepsy [23]. Surprisingly, 10%-20% of epilepsy cases are due to post-traumatic brain injury; however, little is known about the neuronal damage progression, and no treatment prophylaxis exists to prevent late-onset seizures from occurring after head trauma [24]. Patients who had their first seizure during the first year of life did not have any schooling (p<0.0001) and had learning difficulties (p<0.00001). This is similar to other studies demonstrating that people with epilepsy experience educational obstacles and scholastic difficulties in catching up to their peers [19]. Those who had their first seizure during the toddler years were associated with febrile convulsions (p=0.0004), while those who experienced their first seizure between the ages of 50 and 64 were found to have a history of neurological disorders (p=0.0001). Surprisingly, a family history of epilepsy and consanguinity were not significantly related to any seizure subtype in this study, although nearly one-fourth of patients were reported to have a family history of epilepsy (24.8%) and 36.4% had one of consanguinity. Several studies have reported family history and consanguinity as strong factors for epilepsy [25,26]. Perhaps the location of this study, an urban and modernized region of Saudi Arabia where many people are educated, poses a limitation regarding the true significance of family history, consanguinity, and epilepsy. It is common for patients with epilepsy to suffer psychiatric comorbidities. Therefore, it is prudent that medical management of epilepsy, as well as psychiatric therapy and follow-up, be provided to patients that need these services [27]. Only 7.4% of patients included in this study reported having a psychiatric disorder, and only 4.1% were on treatment. This low proportion may be due to underreporting or stigmatization of mental disorders, psychiatric treatment, and epilepsy [28].

Conclusions

This study highlights the sociodemographic differences between patients in Saudi Arabia and in other areas. It may also point to novel findings regarding the postictal symptoms associated with the various seizure subtypes. Further investigations are needed to support these findings. Other similar studies may be conducted in rural areas of the country to examine the association of family history and consanguinity with epilepsy. Additional awareness needs to be raised regarding the benefits of mental health, and psychiatric support should be readily provided to those with epilepsy.

Human Ethics

Animal Ethics

Consent was obtained or waived by all participants in this study. The Unit of Biomedical Ethics Research Committee at the Faculty of Medicine, King Abdulaziz University, issued approval 199-22. This research had been approved by the Research Ethics Committee (REC) on 17/04/2022. Based on the investigator’s request and the attached documents, the REC is glad to grant final ethical approval for the project.

Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.

The authors have declared that no competing interests exist.
==== Refs
References

1 Epilepsy: a public health imperative 9 2020 2019 https://www.who.int/mental_health/neurology/epilepsy/report_2019/en/
2 The epidemiology of epilepsy Neuroepidemiology Beghi E 185 191 54 2020 31852003
3 The new definition and classification of seizures and epilepsy Epilepsy Res Falco-Walter JJ Scheffer IE Fisher RS 73 79 139 2018 29197668
4 Global health: epilepsy Semin Neurol Ali A 191 199 38 2018 29791945
5 The prevalence of epilepsy and other seizure disorders in an Arab population: a community-based study Seizure Rajeh SA Awada A Bademosi O Ogunniyi A 410 414 10 2001 11700993
6 Level of awareness and attitudes toward epilepsy in Qassim, Saudi Arabia: a cross-sectional study Epilepsy Behav Altowayan R Aloqaily H Almutairi A 66 69 90 2019 30513437
7 Epidemiological study of epilepsy from a tertiary care hospital in kingdom of Saudi Arabia Neurosciences (Riyadh) Shahid R Nazish S Zafar A 223 226 23 2018 30007998
8 Stigmatization and social impacts of epilepsy in Turkey Epilepsy Behav Ak PD Atakli D Yuksel B Guveli BT Sari H 50 54 50 2015 26117273
9 Epilepsy awareness in Saudi Arabia Neurosciences (Riyadh) Khan SA 205 206 20 2015 26166586
10 Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration PLoS Med Vandenbroucke JP von Elm E Altman DG 0 4 2007
11 Epilepsy in adults Lancet Thijs RD Surges R O'brien TJ Sander JW 689 701 393 2019 30686584
12 Prevalence and incidence of epilepsy J. Neurol Fiest KM Sauro KM Wiebe S 296 303 88
13 Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies Neurology Fiest KM Sauro KM Wiebe S 296 303 88 2017 27986877
14 Exercise, diet, health behaviors, and risk factors among persons with epilepsy based on the California Health Interview Survey, 2005 Epilepsy Behav Elliott JO Lu B Moore JL McAuley JW Long L 307 315 13 2008 18490199
15 Simple partial seizure Kumar A Maini K Arya K Sharma S Treasure Island, FL StatPearls Publishing 2022 https://www.ncbi.nlm.nih.gov/books/NBK500005/
16 Frequency and prognosis of convulsive status epilepticus of different causes: a systematic review Arch Neurol Neligan A Shorvon SD 931 940 67 2010 20697043
17 Signs and symptoms of the postictal period in epilepsy: a systematic review and meta-analysis Epilepsy Behav Subota A Khan S Josephson CB 243 251 94 2019 30978637
18 The postictal state - what do we know? Epilepsia Pottkämper JC Hofmeijer J van Waarde JA van Putten MJ 1045 1061 61 2020 32396219
19 [School failure and pediatric epilepsy] (Article in Spanish) Rev Neurol García-Peñas JJ 0 8 60 2015 https://ibecs.isciii.es/cgi-bin/wxislind.exe/iah/online/?IsisScript=iah/iah.xis&src=google&base=IBECS&lang=e&nextAction=lnk&exprSearch=134374&indexSearch=ID
20 Epilepsy disorders and treatment modalities NASN Sch Nurse Kaeberle J 342 344 33 2018 https://doi.org/10.1177/1942602X18785246 30024820
21 Molecular diagnosis of patients with epilepsy and developmental delay using a customized panel of epilepsy genes PLoS One Ortega-Moreno L Giráldez BG Soto-Insuga V 0 12 2017
22 Early onset developmental delay and epilepsy in pediatric patients with WDR45 variants Eur J Med Genet Chen H Qian Y Yu S 149 160 62 2019 29981852
23 Febrile seizures: are they truly benign? Longitudinal analysis of risk factors and future risk of afebrile epileptic seizure based on the national sample cohort in South Korea, 2002-2013 Seizure Choi YJ Jung JY Kim JH 77 83 64 2019 30594055
24 Traumatic brain injury and epilepsy: underlying mechanisms leading to seizure Seizure Lucke-Wold BP Nguyen L Turner RC 13 23 33 2015 26519659
25 Consanguinity and epilepsy in Oran, Algeria: a case-control study Epilepsy Res Chentouf A Talhi R Dahdouh A Benbihi L Benilha S Oubaiche ML Chaouch M 10 17 111 2015 25769368
26 Copy number variations in Saudi family with intellectual disability and epilepsy BMC Genomics Naseer MI Chaudhary AG Rasool M 757 17 2016 27766957
27 Management of psychiatric and neurological comorbidities in epilepsy Nat Rev Neurol Kanner AM 106 116 12 2016 26782334
28 Epilepsy coexisting with depression Pharmacol Rep Błaszczyk B Czuczwar SJ 1084 1092 68 2016 27634589